About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

CardioInsight 1 RBBB | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNANCT05555966

CardioInsight 1 RBBB

Cardiac resynchronization therapy (CRT) is an established therapy for symptomatic heart failure patients. However, there are still 30 to 40% of studied patients being nonresponder to CRT. The plausibl...

Lead sponsor: Chinese University of Hong Kong•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Daniel Xu

CONTACT

35051518 [email protected]

Sponsors

Lead Sponsor

Chinese University of Hong Kong

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adult (aged 18 or above) of both sexes
•Ischemic or non-ischemic cause of heart failure
•QRS duration \> 120 ms, non-left bundle branch block (LBBB) type of conduction disturbance
•NYHA class III or above
•Informed consent by the patient
•Already received stable dose of guideline directed medical therapy for at least 3 months

Exclusion Criteria

•LBBB patients
•Pregnant women
•Participation in another study
•Patient with contraindication to left ventricle catheterization by a retrograde aortic approach

Related studies

Effect of Personalized Follow-up in Adapted Physical Activities in Subjects With Chronic Heart Failure.

NCT06222762 · Heart Failure

Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades

NCT06052475 · Pacing-Induced Cardiomyopathy, Heart Failure

Non-interventional Study on Guideline Directed Medical Therapy for Patients With Heart Failure (HF) in Germany

NCT06675552 · Heart Disease, Heart Failure, and more

A Study to Learn More About the Safety of the Drug Vericiguat in Japanese People With Chronic Heart Failure Who Will be Receiving Vericiguat Under Real-world Conditions

NCT05666518 · Chronic Heart Failure

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

NCT05677100 · Heart Failure, Cardiorenal Syndrome, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 27, 2022Terms

Trial snapshot

StatusUNKNOWN

PhaseNA

Enrollment93

Start dateSep 2017

Last updatedSep 27, 2022

Condition

Locations shown

The Chinese University of Hong Kong

Shatin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 27, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions